Skip to main content
Premium Trial:

Request an Annual Quote

DNAStar Awarded NIH SBIR Grant for Clinical NGS Analysis Software

Premium

DNAStar said this week that that it has received a fast-track Phase I and Phase II Small Business
Innovation award from the National Institutes of Health to support the development of sequence analysis software for the clinical research market.

Tom Schwei, vice president and general manager of DNAStar, said in a statement that the funding "will be used to accelerate the speed with which we can move from the general research market into the clinical research market."

Schwei told BioInform that the company has been awarded $150,000 under Phase I of the grant. Under the fast-track model, a Phase II award of $500,000 to $1 million will be awarded if funding is available, he said.

The project will involve "several clinical trial studies with numerous collaborators and clinical trial sponsors" that will involve sequencing "hundreds of samples," Schwei said.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.